China Dna Sequencing Market Size & Outlook, 2023-2030
China dna sequencing market, 2018-2030 (US$M)
Related Markets
China dna sequencing market highlights
- The China dna sequencing market generated a revenue of USD 667.3 million in 2023 and is expected to reach USD 3,782.1 million by 2030.
- The China market is expected to grow at a CAGR of 28.1% from 2024 to 2030.
- In terms of segment, instruments was the largest revenue generating product & service in 2023.
- Services is the most lucrative product & service segment registering the fastest growth during the forecast period.
Dna sequencing market data book summary
| Market revenue in 2023 | USD 667.3 million |
| Market revenue in 2030 | USD 3,782.1 million |
| Growth rate | 28.1% (CAGR from 2023 to 2030) |
| Largest segment | Instruments |
| Fastest growing segment | Services |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Consumables, Instruments, Services |
| Key market players worldwide | Thermo Fisher Scientific Inc, Agilent Technologies Inc, Illumina Inc, Qiagen NV, Roche Holding AG, Macrogenics Inc, PerkinElmer, Pacific Biosciences of California Inc, BGI Group, BGC Group Inc Ordinary Shares Class A, Bio-Rad Laboratories Inc, Myriad Genetics Inc, PierianDx, Eurofins Scientific SE |
Other key industry trends
- In terms of revenue, China accounted for 5.4% of the global dna sequencing market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China dna sequencing market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 3,782.1 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
DNA Sequencing Market Scope
DNA Sequencing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
China dna sequencing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to dna sequencing market will help companies and investors design strategic landscapes.
Instruments was the largest segment with a revenue share of 49.63% in 2023. Horizon Databook has segmented the China dna sequencing market based on consumables, instruments, services covering the revenue growth of each sub-segment from 2018 to 2030.
China has one of the fastest-growing and most advanced DNA sequencing market. In 2020, the country’s genetic testing companies raised approximately USD 3 billion in financing. NGS can improve human health by enabling early diagnosis of rare diseases, more pathogen monitoring, and improved outcomes for cancer patients.
Each year, 4 million people in the country are diagnosed with cancer, accounting for nearly 30% of cancer-related deaths globally. Thus, NGS testing is the only way to meet the unmet needs of patients by offering personalized therapies.
The Beijing Genomics Institute is a prominent body in the DNA sequencing market. Owing to the presence of prominent NGS sequencing centers such as BGI, China accounts for a significant share of the global DNA sequencing market.
Reasons to subscribe to China dna sequencing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of China dna sequencing market databook
-
Our clientele includes a mix of dna sequencing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China dna sequencing market , including forecasts for subscribers. This country databook contains high-level insights into China dna sequencing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
China dna sequencing market size, by product & service, 2018-2030 (US$M)
China DNA Sequencing Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
